1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK (R01 Clinical Trial Optional) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This funding opportunity sought US domestic research projects addressing how food insecurity affects HIV comorbidities, coinfections, and complications within the mission of the NIDDK.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible entities include Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-bas…. Confirm the full requirements in the official notice before applying.
Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK (R01 Clinical Trial Optional) is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Alaska. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NIH Organ-on-Chip Diabetes SBIR: Microphysiological Systems for Diabetes, Kidney, and Urologic Complications Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This highlighted topic encourages collaborative research applying human microphysiological systems (MPSs), or organ-on-chip platforms, to cell and tissue types relevant to diabetes and its kidney and urologic complications. High-priority areas include systems with at least two diabetes-relevant human tissues, validation of diabetes pathophysiology, studies of crosstalk between tissues, and models with mature cell types and interacting compartments.
NIDDK Small Business Programs (SBIR/STTR) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK participates in SBIR and STTR programs to support innovative research conducted by small businesses with the potential for commercialization. While their primary focus areas are digestive diseases, nutritional disorders, and obesity, innovations in medical devices that could have an impact on related circulatory or chronic conditions might be considered.
NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes related to sickle cell disease research. The R21 mechanism encourages the development of new research activities in categorical program areas.